NCT00002034View on ClinicalTrials.gov

A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

Not specified

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Zidovudine

DRUG

Ganciclovir

Trial Locations (9)

29204

Dr Alfred F Burnside Jr, Columbia

30076

Dr Winkler Weinberg, Roswell

33125

Miami Veterans Administration Med Ctr, Miami

35294

Univ of Alabama at Birmingham, Birmingham

77550

Univ TX Galveston Med Branch, Galveston

94115

Stanford at Kaiser / Kaiser Permanente Med Ctr, San Francisco

94609

Summitt Med Ctr / San Francisco Gen Hosp, Oakland

117948153

SUNY / Health Sciences Ctr at Stony Brook, Stony Brook

Unknown

Southern Alberta HIV Clinic / Foothills Hosp, Calgary

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00002034 - A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS | Biotech Hunter | Biotech Hunter